Carcinosarcoma of the Liver: A Case Report

Primary hepatic carcinosarcoma is a rare tumor comprised of a mixture of carcinomatous and sarcomatous elements. Less than 20 adequately documented cases have been reported, however the imaging features of two cases were briefly described. We present here a case of carcinosarcoma of the liver in a 46-year-old woman, which was confirmed based on pathology. Imaging showed a large mass with large necrotic portions, small cystic portions, calcifications and bone formations.

Evaluation of Newly Developed Small (< or = 20 mm) Enhancing Nodules on the Arterial Phase CT after Transcatheter Arterial Cheomoembolization in Patients with Hepatocellular Carcinoma

PURPOSE: We assessed the clinical significance of newly developed small (< or = 20 mm) early-enhancing hepatic nodules on arterial phase CT after performing transcatheter arterial cheomoembolization (TACE) in patients suffering with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: We searched for the radiologic reports that showed small early enhancing nodule (< or = 20 mm) on the arterial phase imaging of follow-up CT after performing TACE. Thirty-seven lesions in 30 patients had round or oval shaped nodules and the numbers of nodule for one patient was less than five. We classified the nodules by size, location and the decreased attenuation seen on the portal venous phase. The latest follow-up CTs were reviewed to assess the nodules for the final diagnosis. All the follow-up CTs were two-phase spiral CT scans. RESULTS: Twenty-five (67%) of the 37 nodules were recurred HCC, as was determined on the basis of their interval growth and lipiodol uptake after TACE. Among the 37 nodules, seven (18%) disappeared on the latest follow-up CT and they were considered as definite pseudolesions. The remaining five (15%) were stable in size or they decreased in size, and they were considered as probable pseudolesions. The mean size of the nodules on initial CT was 11 mm. The mean size of the malignant nodules was 11+/-4.2 mm and that of the benign pseudolesions was 9+/-4.9 mm. The nodules located on the hepatic surface were possible to definite benign pseudolesions (p<0.05). All ten low attenuated nodules seen on the portal phase were HCCs. CONCLUSION: When seen on the follow-up CT scans of HCC patients after performing TACE, the newly developed small early-enhancing nodules were considered to have high potential of being HCC by their locations and enhancing patterns.

Liver Involvement of Multiple Myeloma Mimicking Intrahepatic Cholangiocarcinoma: A Case Report

Nodular hepatic involvement of multiple myeloma is very rare. We report here on a case of nodular hepatic involvement of multiple myeloma that mimicked intrahepatic cholangiocarcinoma. In patients with multiple myeloma, hepatic involvement of the multiple myeloma might be included in the differential diagnosis of hepatic mass.

Liver Involvement of Multiple Myeloma Mimicking Intrahepatic Cholangiocarcinoma: A Case Report

Nodular hepatic involvement of multiple myeloma is very rare. We report here on a case of nodular hepatic involvement of multiple myeloma that mimicked intrahepatic cholangiocarcinoma. In patients with multiple myeloma, hepatic involvement of the multiple myeloma might be included in the differential diagnosis of hepatic mass.

Fibrolamellar Hepatocellular Carcinoma Mimicking Malignant Lymphoma: A Case Report

Fibrolamellar hepatocelluar carcinoma is a distinct clinicopathologic variant of hepatocellular carcinoma. We describe here the sonographic and CT findings of fibrolamellar hepatocellular carcinoma in a 17-year-old patient that mimicked hepatic malignant lymphoma due to the multiple small hypoattenuating nodules and extensive lymphadenopathy that we observed. We also include a review of the relevant literatures.

Hepatic Metastasis of Thymoma: A Case Report

Thymoma is the most common neoplasm in the anterior mediastinum, and extrathoracic involvement is rare. Moreover, cystic liver metastasis is extremely rare; few cases have been reported in the literature to date. We report here on a case of cystic liver metastasis of thymoma treated with surgical resection, describing the ultrasonography, CT and MRI findings.

Preoperative Detection of Hepatic Metastases from the colorectal Cancers: Comparison of Dual-phase CT scan, Mn-DPDP enhanced MRI, and combination of CT and MRI

PURPOSE: To determine the usefulness of additional Mn-DPDP MRI for preoperative evaluation of the patients with colorectal cancers by comparison of dual-phase CT scan, Mn-DPDP enhanced MRI and combination of CT and MRI. MATERIALS AND METHODS: Fifty-three colorectal cancer patients with 92 metastatic nodules underwent dualphase (arterial and portal) helical CT scan and Mn-DPDP MRI prior to surgery. The indication of MRI was presence or suspected of having metastatic lesions at CT scan and/or increased serum carcinoembryonic antigen (CEA) levels (10 ng/mL or more). The diagnosis was established by the combination of findings at surgery, intraoperative ultrasonography, and histopathologic examination. Two radiologists interpreted CT, MRI, and combination of CT-MRI at discrete sessions and evaluated each lesion for location, size, and intrinsic characteristics. The lesions were divided into three groups according to their diameter; 1cm 2 cm. Diagnostic accuracy was evaluated using the alternative-free response receiver operating characteristic method. Detection and false positive rate were also evaluated. RESULTS: In the lesions smaller than 1 cm, detection rate of combined CT-MRI was superior to CT or MRI alone (82%, p = 0.036). The mean accuracy (Az values) of combined CT and MRI was significantly higher than that of CT in the lesions smaller than 2 cm (1 cm <, p=0.034; 1-2 cm, p=0.045). However, there was no significant difference between MRI and combined CT-MRI. The false positive rate of CT was higher than those of combined CT-MR in the lesions smaller than 1 cm (28 %, p=0.023). CONCLUSION: Additional MRI using Mn-DPDP besides routine CT scan was helpful in differentiating the hepatic lesions (< 2 cm) and could improve detection of the small hepatic metastases (< 1 cm) from colorectal carcinoma.

Follow-up Results After Negative Findings on Unenhanced Hepatic MR Imaging for Hepatic Metastasis from Rectal Cancer

OBJECTIVE: To assess the follow-up results after negative findings on unenhanced hepatic MR imaging in rectal cancer patients who have undergone locally curative surgery. MATERIALS AND METHODS: From all pertinent imaging reports and medical records, we selected 255 patients who had negative results on unenhanced hepatic MR imaging. When selecting patients who had undergone curative resection, the following patients were excluded from the study: 1) patients in whom extrahepatic metastases were detected on preoperative staging work-ups, 2) patients in whom the surgery was judged to be non-curative due to peritoneal seeding or local aggressiveness. Cases with follow-up periods of less than 18 months were also excluded, as these cases were considered insufficient to confirm the negative outcomes. Thus, a total of 149 patients were ultimately enrolled in our study. The follow-up results of unenhanced MR imagings were assessed according to the assumption that the newly developed hepatic metastases had been false-negative lesions on preoperative MR image. RESULTS: During a median follow-up period of 29.3 months, 25 hepatic metastases were detected in 13 patients (8.7%), which indicated a negative predictive value of 91.3%. CONCLUSION: Unenhanced hepatic MR imaging provides a high negative predictive value with regard to the detection of hepatic metastasis in the preoperative evaluation of rectal cancer.

Pigmented Liver Cell Adenoma with Nodule-in-Nodule Appearance: Case Report

Pigmented liver cell adenoma is very rare benign hepatic tumor and only four cases have been reported in the literature until now. We experienced one case of pigmented liver cell adenoma with nodule-in-nodule appearance, and we report on the ultrasonographic, CT and pathologic findings.

Hepatoblastoma in a Patient with Familial Adenomatous Polyposis: Case Report

Familial adenomatous polyposis and hepatoblastoma are rare conditions; the latter is closely related to the FAP gene. We describe the imaging findings of hepatoblastoma in a patient with polyposis coli.

Assessment of Angiogenesis of Hepatic VX2 Carcinoma: Usefulness of Perfusion CT

PURPOSE: To investigate the perfusion characteristics of VX2 carcinoma and liver parenchyma in an animal model, and to evaluate the usefulness of perfusion CT in assessing the angiogenesis of hepatic VX2 carcinoma. MATERIALS AND METHODS: Ten rabbits (control, 5; VX2 carcinoma, 5) weighing 2.5 to 3.5 (average, 3.1) Kg were involved in this study. Between 7 and 14 days after implanting VX2 carcinoma, ultrasonography and CT were performed for the purpose of detecting this. Using the cine mode and involving four simultaneous sections, four perfusion CT images were obtained every second for 60 seconds. One radiologist measured the size of the region of interest (ROI) at each liver location, and using the time-density curves for each tumor and normal liver, semi-quantitative perfusion parameters -namely blood volume, mean transit time (MTT), blood flow, and time-to-peak enhancement-were determined. The microvascular densities (MVD) of VX2 tumors and normal liver were correlated with the perfusion CT findings. RESULTS: In the control group, there were no significant differences in perfusion parameters between the left and right hepatic lobes. In the VX2 carcinoma group, there were significant differences between the lobe containing the tumor and adjacent hepatic lobes with respect to blood volume (34.80 vs. 27.2 ml/100 g), MTT (14.1 vs. 19.4 sec), blood flow (119.7 vs. 84.3 ml/100 g/min), and time-to-peak (32.4 vs. 36.9 sec) (p<0.05). The blood volume (27.2 ml/100g) of the hepatic lobe with the VX2 tumor was higher than that of normal liver (22.8 ml/100 g) (p< 0.05), but blood flow (84.3 vs. 66.8 ml/100 g/min), MTT (19.4 vs. 21.3 sec) and time-to-peak (36.9 vs. 38.7 sec) values were not different. The MVD of VX2 tumors was higher than that of normal liver (p<0.05), and significantly higher than that of adjacent and contralateral liver (p<0.05). CONCLUSION: At perfusion CT, blood volume and blood flow of VX2 carcinomas increased more than those of normal liver, as were both mean transit time and time-to-peak. It was confirmed histopathologically that the angiogenesis of VX2 carcinoma was higher than that of normal liver. In conclusion, perfusion CT may be a practically useful diagnostic tool capable of reflecting the neoplastic angiogenesis of the liver.

Marginal Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Relationship between Distance from Hepatic Capsule to Tumor and Recurrence Period

PURPOSE: To examine the relationship between distance from hepatic capsule to tumor and recurrence among hepatocellular carcinoma patients in whom marginal recurrence was noted after radiofrequency ablation therapy. MATERIALS AND METHODS: Between January 2000 and December 2001, hepatocellular carcinoma patients with a tumor 5 cm or less in size and located 2 cm or less from the hepatic capsule underwent radiofrequency ablation therapy. We subsequently selected 37 patients (41 tumors) in whom immediate CT demonstrated complete tumor ablation and follow-up CT showed marginal recurrence. Tumors were grouped according to their distance from the hepatic capsule: Group I, adhered to the capsule; Group II, less than 1 cm from it; Group III, 1-2 cm distant. Of the 41 tumors, 22 were assigned to Group I, six to Group II, and 13 to Group III. Mean tumor size was 3.2 cm, and inter-group variation was small (Group I, 3.3 cm; Group II, 2.9 cm; Group III, 3.1 cm). Follow-up CT was used to determine marginal recurrence, and for inter-group comparison and the assessment of statistical significance, the t test was employed. RESULTS: Marginal recurrence was noted at mean 5.5 months (2.7 months in Group I, 3.0 months in Group II, and 10.5 months in Group III). The t test revealed significant difference between Group I and III (p<0.0001) but not between Groups I and II, or II and III. If '1 cm from hepatic capsule' was the criterion for classification, and Group I and II were combined and compared with Group III, there was significant difference between the two groups (<0.0001). CONCLUSION: Tumors which adhered to the hepatic capsule or were less than 1 cm from it recurred sooner than those situated 1-2 cm away.

Epithelioid Hemangioendothelioma of the Liver: Helical CT Findings

PURPOSE: To describe the morphologic features and enhancement patterns of the helical computed tomography (CT) observed in patients with epithelioid hemangioendothelioma (EH) of the liver. MATERIALS AND METHODS: Seven patients (four men and three women; mean age, 41 years) with pathologically proven EHs underwent monophasic (n=2), biphasic (n=2) or triphasic (n=3) helical CT, and the findings were retrospectively analysed. The morphologic features to which attention was directed were tumor number, size, location, shape, margin, surface, the presence of adjacent capsular retraction, vascular encasement and confluent mass formation, while the enhancement pattern was examined in terms of the appearance and degree of enhancement during the arterial or portal phase, and enhancement change during the portal and equilibrium phases. RESULTS: Six patients had multiple tumors, and one had a single lesion. The maximon diameter of these tumors ranged from 0.5 to 12.0 (mean, 3.2) cm, and almost all occurred in the peripheral portion of the liver. The shape, margin and surface features of the tumors varied: in four patients, the margin was poorly defined and the surface was smooth, while in five, adjacent capsular retraction was observed. Vascular encasement was noted in five of six patients with hepatic vessels abutting the tumors, and in all three who were follow up, the growth pattern involved confluent mass formation. In all patients, many tumors showed either nodular (n=3) or irregular (n=4) peripheral enhancement. In all five patients who underwent multiphasic CT, centripetal enhancement was demoustrated. CONCLUSION: Our results disclosed that most patients with EH had multiple tumors, and that almost all were located in the peripheral portion of the liver and involved capsular retraction. The other common CT findings were vascular encasement and a centripetal enhancement pattern. When these CT findings are observed in patients with hepatic tumors, EH should be included in the differential diagnosis.

Focal Nodular Hyperplasia of the Liver: Triphasic Helical CT Findings

PURPOSE: To analyze the morphologic and enhancement patterns of focal nodular hyperplasia (FNH) of the liver observed at triphasic helical CT. MATERIALS AND METHODS: The triphasic helical CT findings of 15 pathologically-proven FNHs in 15 patients (male: female = 7:8; mean age, 40 years) were retrospectively analyzed. Triphasic helical CT images were obtained at 30 secs (arterial phase), 70 secs (portal phase), and 3 mins (equilibrium phase) after the initiation of contrast injection of a total of 120 mL nonionic contrast material at a rate of 3 mL/sec. Image analysis focused on the morphologic and enhancement patterns of the FNHs. Morphologically, their size and margin conspicuity were determined, as well as the presence or absence of a capsule, central scar, malformed arterial vessel, calcification, and mosaic pattern. As for the enhancement pattern, the degree of tumor enhancement (hyper-, iso-, or hypoattenuation) was compared with the surrounding hepatic parenchyma at each phase. All hyperattenuating FNHs were further analyzed after dividing them into two groups, strongly and weakly enhanced. RESULTS: Ten of the 15 tumors were less than 3 cm in diameter. With regard to the other morphologic parameters, a central scar, malformed arterial vessel, and capsule were found in four, four, and five FNHs, respectively. Eleven FNHs showed hyperattenuation, with strong enhancement at the arterial phase. During the portal and equilibrium phases, the enhancement pattern changed to iso- or hypoattenuation in nine and 13 FNHs, respectively. Of six hyperattenuating FNHs at the portal phase, five were weakly enhanced. CONCLUSION: Though our sample was small, we found that FNHs were hyperattenuating lesions, strongly enhanced at the arterial phase but iso- or hypoattenuating during the portal and equilibrium phases. A central scar, malformed arterial vessel, and capsule were observed fairly frequently. Thus, for the differentiation of FNH from other hypervascular hepatic tumors, precise recognition of their CT findings is important.

The Factors Related to Local Recurrence after Radiofrequency Thermal Ablation of Hepatic Malignancies : Assessment of Spiral CT Findings

PURPOSE: To determine the factors that are related to local recurrence after Radiofrequency thermal ablation (RFTA) of hepatic tumors. MATERIALS AND METHODS: We selected 30 patients with 51 hepatic nodules less than 5 cm in diameter (HCC, n=33; metastasis, n=18) who underwent RF thermal ablation between May 1999 and April 2000. Ablation was defined as 'complete'if immediately post-procedual CT showed that a nodule's margin was completely covered by ablation. Every three months, follow-up CT scans were examined for signs of local recurrence, and a nodule was assessed in terms of its size, the histologic diagnosis, adjacent vessels, perfect ablation (a safety margin of more than 5mm beyond the tumor margin), and whether hyperemia was observed after ablation. Finally, a group in which there was local recurrence (group A, n=15) and another showing no recurrence (group B, n=36) were compared. RESULTS: Mean nodule size in group A and group B was 3.26 and 2.24 cm, respectively. Local recurrence was noted in 7 of 33 HCC nodules (21.2%), and in 8 of 18 (44.4%) which were metastatic. There was recurrence in 9 of 31 nodules with adjacent vessels (29.0%), and in 6 of 20 (30%) without adjacent vessels. In two of 17 perfectly ablated nodules (11.8%) there was local recurrence, but this was observed in 13 of 34 imperfectly ablated nodules (38.2%). Finally, local recurrence was seen in 14 of 36 nodules showing hyperemia (38.9%) but in one of 15 (6.7%) without hyperemia. Using chi-square analysis, it was thus shown that with regard to local recurrence, tumor size, perfect ablation and peritumoral hyperemia were statistically significant factors (p<0.05). CONCLUSION: Local recurrence after RF thermal ablation of hepatic tumors clearly increases in nodules which are larger. The degree to which ablation is perfect, and the presence of peritumoral hyperemia, may be factors related to the local recurrence observed after RFTA.

Hepatocellular Carcinoma: Comparison Study on Detecting Tumor Vascularity among Various Imaging Techniques

PURPOSE: To compare the detectability of tumor vascularity using triphasic spiral CT, angiography, CT during hepatic arteriography(CTHA) and single-level dynamic CTHA(SLD-CTHA). MATERIALS AND METHODS: Seventy-nine pathologically confirmed nodular hepatocellular carcinomas(HCCs) in 77 patients were included in this study. Sixty patients were male and 17 were female, and their ages ranged from 31 to 77 (average, 57.4) years. HCCs were classified into three groups according to the size: less than 2 cm (n=20), 2 -4 cm (n=32), and more than 4 cm (n=27) in diameter. If a portion of tumor demonstrated greater enhancement than surrounding liver parenchyma, vascularity was deemed to be present. Detectability by each imaging technique was compared according to size and overall. RESULTS: Hypervascularity was frequently detected by SLD-CTHA [90.9%(40/44)], followed by CTHA[88.0%(66/75)], angiography [80.3%(61/76)], triphasic spiral CT [72.4%(42/58)]. In the less than 2 cm group, detectability rates for triphasic spiral CT, angiography, CTHA and SLD-CTHA were 53.3%(8/15), 55.6%(10/18), 76.5%(13/17) and 87.5%(6/7), respectively. while the 2 -4 cm group demonstrated corresponding figures of 71.4%(15/21), 78.1%(25/32), 84.4%(27/32) and 86.4%(19/22). In the more than 4 cm group, the rate for triphasic spiral CT was 86.4%(19/22), while for angiography, CTHA and dynamic CTHA, it was 100%. CONCLUSION: In the detection of hypervascularity of HCC, SLD-CTHA showed the highest rate, followed by CTHA, angiography, and triphasic spiral CT. In HCCs less than 4 cm in diameter, the corresponding ordering was SLD-CTHA, CTHA, angiography and triphasic spiral CT, but in HCCs of more than 4 cm, angiography, CTHA and SLD-CTHA detected hypervascularity equally well. Lesion size most affected the findings of angiography.

Nodular Hepatic Involvement of Malignant Lymphoma:Enhancement Patterns on Dual Phase CT

PURPOSE: To evaluate the enhancement patterns revealed by dual-phase CT, and other characteristic features of nodular hepatic involvement of malignant lymphoma, and to determine the usefulness of this imaging modality in the differentiatial diagnosis of hepatic masses. MATERIALS AND METHODS: Seven cases that pathologically confirmed as nodular hepatic involvements of malignant lymphoma among patients who underwent dual-phase CT for the staging or follow-up of malignant lymphoma, and two that confirmed as primary lymphoma among patients who underwent dual-phase CT for differential diagnosis of nodular hepatic masses were evaluated. There were eight cases of non-Hodgkin 's lymphoma (NHL) and one of Hodgkin 's disease(HD). The findings were analysed in terms of the number, size, and contour pattern of the masses, the enhancement pattern seen on dual-phase CT, and whether or not the vascular structure of the mass was normal. RESULTS: Primary lymphomas were present in two patients(single mass, n=1; multiple nodules, n=1) and secondary lymphomas in seven (single mass, n=6; multiple nodules, n=1). The maximum size of main masses was mean 5.1(range, 2-12) cm, and the contor was smooth in three cases, ill-defined in three and lobulated in three. During the early phase, five patients showed homogeneous low attenuation, and heterogeneous enhancement was observed in four. During the late phase, three of the five showed peripheral enhancement and the other two showed the same low attenuation, while two of the four showed central low attenuation, one showed iso attenuation, and one showed heterogeneous enhancement. In four of the patients whose main mass was larger than the mean, vascular shadow passed through the mass (left portal vein, n=2; branches of the right portal vein, n=1; and branches of the hepatic artery, n=1). CONCLUSION: Where dual-phase CT demonstrated nodular hepatic involvement of malignant lymphoma, contrast enhancement varied and so differentiation from other hepatic masses such as metastatic adenocarcinoma and hepatocellular carcinoma was therefore difficult. Homogeneity and a lack of necrosis, even though a mass is large and has a smooth well-defined contour, no capsulation and normal vasculature, may suggest the nodular hepatic involvement of malignant lymphoma.

Nodular Hepatocellular Carcinoma: Findings of Single-Level Dynamic CT During Hepatic Arteriography

PURPOSE: To evaluate the hemodynamics of nodular hepatocellular carcinoma (HCC) using single-level dynamic CT during hepatic arteriography (CTHA) according to the size of the nodule. MATERIALS AND METHODS: Forty 40 patients with nodular HCC confirmed histologically or radiologically underwent single-level dynamic CTHA. Contrast media was injected via the hepatic artery for 20 seconds at a rate of 1.2 ml/sec. Images were obtained prior to this and thereafter at 3-second intervals until 30 seconds after the start of injection, and additional images at 45 and 60 seconds. The CTHA findings were retrospectively reviewed, and cases were assigned to one of three groups, according to the size of the tumor [ 5 cm (group III, n =16)]. We focused on onset time of contrast enhancement (CE), peak CE time and density, and duration of plateau. The patterns of CE were classified as homogeneous, heterogeneous, peripheral, or "nodule in nodule ". RESULTS: The onset time of CE was 3 seconds and mean peak CE time was 18.8 seconds. A plateau was noted in all groups (mean duration, 6.8 seconds). Mean peak CE time and density were 16.5 seconds and 294.1 HU in group I, 18.5 seconds and 324.1 HU in group II, and 20.1 seconds and 114.0 HU in group III. The most frequent pattern of CE (83%) was homogeneous, and this was found in group I. The small HCC group (group I) showed a faster mean peak CE time than the large group (group III) (p < 0.05), and this latter showed a lower peak CE density than the other groups (p < 0.05). In groups II and III, "nodule in nodule "(72%) and heterogeneous patterns (69%) were, respectively, the most frequent findings. CONCLUSION: Single-level dynamic CTHA is useful in evaluating the hemodynamics of HCC.

Hepatocellular Carcinoma with Bile Duct Involvement: Computed Tomographic (CT) Findings

PURPOSE: To describe the radiologic features of computed tomography(CT) in hepatocelluar carcinoma(HCC) with bile duct involvement. MATERIALS AND METHODS: We retrospectively analyzed the two phase spiral CT findings of 31 patients in whom HCC with bile duct invasion (n=28) or compression (n=3), was diagnosed. Eight of these underwent follow-up CT after transarterial chemoembolization. We analyzed the size, type, location, enhancement pattern, and lipiodol retention of parenchymal and intraductal masses, as well as their and lymphadenopathy. RESULTS: In all patients with bile duct invasion, single or multiple masses were demonstrated in the bile ducts. Intraductal masses showed the same enhancement characteristics as the parenchymal mass (kappa 0.550, p < .001), and were contiguous to this mass. In 14 of 28 patients, intraductal masses filled the peripheral intrahepatic bile ducts and extended to the common bile ducts. In the other 14, the parenchymal mass extended to the area of the porta hepatis and then directly invaded the large ducts. In nine of the 28 patients, there was a hypoattenuated cleft between the intraductal mass and ductal wall. In six, a parenchymal mass was not apparent (n = 2), or was smaller than 2cm (n = 4). In five of eight patients (62.5%), follow-up CT after transarterial chemoembolization showed compact or partial lipiodol retention within the intraductal mass. In patients with bile duct compression, perihilar lymph nodes were noted along with the dilated intrahepatic duct but no intraductal mass was demonstrated in the duct. CONCLUSION: Hepatocellular carcinomas cause bile duct dilatation either by direct invasion or by extrinsic compression of the bile duct with surrounding enlarged nodes. For the diagnosis of this condition, CT is helpful.

CT Findings of Ciliated Hepatic Foregut Cyst Mimicking Metastasis: A Case Report

Ciliated hepatic foregut cyst (CHFC) is a rare benign lesion consisting of ciliated pseudostratified columnar epithelium, loose subepithelial connective tissue, a smooth muscle layer, and an outer fibrous capsule. We encountered a patient with retroperitoneal and posterior mediastinal neurilemmoma and additional CHFC mimicking metastasis. Abdominal CT examination demonstrated that the posterior mediastinal and retroperitoneal lesions were lobulated, well-defined tumors with a neural foraminal extension that were pathologically confirmed as neurilemmomas. Unenhanced CT indicated that the additional lesion was a slightly hypodense mass relative to surrounding parenchyma at the medial segment of the left lobe of the liver, and after the IV ad-ministration of contrast material, the lesion did not show enhancement.